Luciferase Stable IMR-32 Cell Line | T6100

abm | Luciferase Stable IMR-32 Cell Line | T6100

Luciferase Stable IMR-32 cells are derived from primary stage 4 neuroblastoma with MYCN gene amplification (a characteristic of advanced neuroblastoma). These cells have applications in understanding more about local and metastatic tumor growth patterns and exploring new cancer therapeutics.

Biosafety:

II

Organism:

Human (H. sapiens)

Source Organ:

Brain

Growth Properties:

Adherent

Morphology:

Neuronal

Clones:

N/A

Passage Number:

N/A

Population Doner:

20 hours

Seeding Density:

30,000 - 40,000 cells/cm²

Markers:

Luciferase (gene insertion), PcDNA3-Luc2 vector, neomycin resistance

Applications:

For Research Use Only

Doner Gender:

N/A

Donor Ethnicity:

Not disclosed

Knockdown Method:

N/A

Induction:

N/A

Overexpression:

N/A

Freeze Thaw:

N/A

Propagation:

The base medium for this cell line is Prigrow II medium available at abm

Preservation:

1. Freeze Medium: Complete growth medium with 20% FBS and 10% DMSO.
2. Storage Temperature: Liquid nitrogen vapour phase.

Quality Control:

1) Western blot; 2) Bioluminescence; 3) Inner salt (MTS) assay

Tumorgenicn:

N/A

Shipping Conditions:

Dry Ice

Storage Contidions:

-180°C